Search research articles
Contact Us
Filters
Showing results (111-120 of 134) with videos related to
Page
of 14
Sort By:
HIV Clinical Trials
|
August 22, 2014
Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: a multicenter randomized double-blind placebo-controlled trial
Marina B Klein, Terry Lee, Marie-Josée Brouillette, et al.
Digestive Diseases and Sciences
|
February 22, 2023
Efficacy and Safety of Dual Targeted Therapy for Partially or Non-responsive Inflammatory Bowel Disease: A Systematic Review of the Literature
Elliot M Berinstein, Jessica L Sheehan, Janson Jacob, et al.
Digestive Diseases and Sciences
|
October 27, 2023
Correction to: Efficacy and Safety of Dual Targeted Therapy for Partially or Non‑responsive Inflammatory Bowel Disease: A Systematic Review of the Literature
Elliot M Berinstein, Jessica L Sheehan, Janson Jacob, et al.
Sexually Transmitted Diseases
|
April 1, 1999
Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis
C H Livengood, D E Soper, K L Sheehan, et al.
Clinical and Translational Gastroenterology
|
March 7, 2023
Self-Efficacy and the Impact of Inflammatory Bowel Disease on Patients' Daily Lives
Jessica L Sheehan, LaVana Greene-Higgs, Linnea Swanson, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
February 3, 2016
A Geospatial Analysis of Severe Firearm Injuries Compared to Other Injury Mechanisms: Event Characteristics, Location, Timing, and Outcomes
Craig D Newgard, Brittany J Sanchez, Eileen M Bulger, et al.
Molecules (Basel, Switzerland)
|
January 14, 2012
The effect of β-carotene supplementation on the pharmacokinetics of nelfinavir and its active metabolite M8 in HIV-1-infected patients
Nancy L Sheehan, Rolf P G van Heeswijk, Brian C Foster, et al.
ACS Infectious Diseases
|
January 28, 2024
Heterologous Sarbecovirus Receptor Binding Domains as Scaffolds for SARS-CoV-2 Receptor Binding Motif Presentation
Blake M Hauser, Maya Sangesland, Evan C Lam, et al.
Biorxiv : the Preprint Server for Biology
|
March 18, 2024
Immune Signatures of SARS-CoV-2 Infection Resolution in Human Lung Tissues
Devin Kenney, Aoife K O'Connell, Anna E Tseng, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 18, 2024
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity
Alex L Roederer, Yi Cao, Kerri St Denis, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 134) with videos related to
Sort By:
Page
of 14
HIV Clinical Trials
|
August 22, 2014
Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: a multicenter randomized double-blind placebo-controlled trial
Marina B Klein, Terry Lee, Marie-Josée Brouillette, et al.
Digestive Diseases and Sciences
|
February 22, 2023
Efficacy and Safety of Dual Targeted Therapy for Partially or Non-responsive Inflammatory Bowel Disease: A Systematic Review of the Literature
Elliot M Berinstein, Jessica L Sheehan, Janson Jacob, et al.
Digestive Diseases and Sciences
|
October 27, 2023
Correction to: Efficacy and Safety of Dual Targeted Therapy for Partially or Non‑responsive Inflammatory Bowel Disease: A Systematic Review of the Literature
Elliot M Berinstein, Jessica L Sheehan, Janson Jacob, et al.
Sexually Transmitted Diseases
|
April 1, 1999
Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis
C H Livengood, D E Soper, K L Sheehan, et al.
Clinical and Translational Gastroenterology
|
March 7, 2023
Self-Efficacy and the Impact of Inflammatory Bowel Disease on Patients' Daily Lives
Jessica L Sheehan, LaVana Greene-Higgs, Linnea Swanson, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
February 3, 2016
A Geospatial Analysis of Severe Firearm Injuries Compared to Other Injury Mechanisms: Event Characteristics, Location, Timing, and Outcomes
Craig D Newgard, Brittany J Sanchez, Eileen M Bulger, et al.
Molecules (Basel, Switzerland)
|
January 14, 2012
The effect of β-carotene supplementation on the pharmacokinetics of nelfinavir and its active metabolite M8 in HIV-1-infected patients
Nancy L Sheehan, Rolf P G van Heeswijk, Brian C Foster, et al.
ACS Infectious Diseases
|
January 28, 2024
Heterologous Sarbecovirus Receptor Binding Domains as Scaffolds for SARS-CoV-2 Receptor Binding Motif Presentation
Blake M Hauser, Maya Sangesland, Evan C Lam, et al.
Biorxiv : the Preprint Server for Biology
|
March 18, 2024
Immune Signatures of SARS-CoV-2 Infection Resolution in Human Lung Tissues
Devin Kenney, Aoife K O'Connell, Anna E Tseng, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 18, 2024
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity
Alex L Roederer, Yi Cao, Kerri St Denis, et al.
Page
of 14